Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and Type 2 diabetes

Molecular and Cellular Endocrinology

Volumn 427, Issue , 2016, Pages 112-123

  Pek, Sharon Li Ting ^a   Sum, Chee Fang ^a   Lin, Michelle Xueqin ^a   Cheng, Anton Kui Sing ^a   Wong, Michael Tack Keong ^a   Lim, Su Chi ^a   Tavintharan, Subramaniam ^a  

^a KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

Adipogenesis; IGFR; MicroRNAs; MTOR; Obesity; Type 2 diabetes

Indexed keywords

GROWTH FACTOR RECEPTOR; INSULIN GROWTH FACTOR RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 100; UNCLASSIFIED DRUG; MICRORNA; MIRN100 MICRORNA, HUMAN; MTOR PROTEIN, HUMAN; SOMATOMEDIN RECEPTOR; TARGET OF RAPAMYCIN KINASE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CELL VIABILITY; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; 3T3 CELL LINE; ADOLESCENT; ANIMAL; BLOOD; CELL CULTURE; COMPLICATION; METABOLISM; MIDDLE AGED; MOUSE; YOUNG ADULT;

3T3 CELLS; ADOLESCENT; ADULT; AGED; ANIMALS; CELLS, CULTURED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MICE; MICRORNAS; MIDDLE AGED; OBESITY; RECEPTORS, SOMATOMEDIN; TOR SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 84961227008     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.03.010     Document Type: Article

References (46)

1. Abbas A., Imrie H., Viswambharan H., Sukumar P., Rajwani A., Cubbon R.M., Gage M., Smith J., Galloway S., Yuldeshava N., Kahn M., Xuan S., Grant P.J., Channon K.M., Beech D.J., Wheatcroft S.B., Kearney M.T. The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium,. Diabetes 2011, 60:2169-2178.
2. American Diabetes Association (2) Classification and diagnosis of diabetes. Diabetes Care 2015, 38(Suppl. l):S8-S16.
3. Back K., Arnqvist H.J. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm. IGF Res. 2009, 19:101-111.
4. Bak E.J., Park H.G., Kim J.M., Yoo Y.J., Cha J.H. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int. J. Obes. Lond. 2010, 34:250-260.
5. Baranova A., Schlauch K., Elariny H., Jarrar M., Bennett C., Nugent C., Gowder S.J., Younoszai Z., Collantes R., Chandhoke V., Younossi Z.M. Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. Obes. Surg. 2007, 17:1111-1118.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Zen K., Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
8. Crawford D.C., Nord A.S., Badzioch M.D., Ranchalis J., McKinstry L.A., Ahearn M., Bertucci C., Shephard C., Wong M., Rieder M.J., Schellenberg G.D., Nickerson D.A., Heagerty P.J., Wijsman E.M., Jarvik G.P. A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk,. J. Lipid Res. 2008, 49:588-596.
9. Doghman M., El Wakil A., Cardinaud B., Thomas E., Wang J., Zhao W., Peralta-Del Valle M.H., Figueiredo B.C., Zambetti G.P., Lalli E. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res. 2010, 70:4666-4675.
10. El-Hefnawy T., Raja S., Kelly L., Bigbee W.L., Kirkwood J.M., Luketich J.D., Godfrey T.E. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 2004, 50:564-573.
11. Estep M., Armistead D., Hossain N., Elarainy H., Goodman Z., Baranova A., Chandhoke V., Younossi Z.M. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2010, 32:487-497.
12. Fang X., Fang L., Liu A., Wang X., Zhao B., Wang N. Activation of PPAR-delta induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells. Br. J. Pharmacol 2015, 172:3728-3736.
13. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., Vasan R.S., Murabito J.M., Meigs J.B., Cupples L.A., D'Agostino R.B., O'Donnell C.J. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
14. Gerin I., Bommer G.T., McCoin C.S., Sousa K.M., Krishnan V., MacDougald O.A. Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E198-E206.
15. Goudriaan J.R., Tacken P.J., Dahlmans V.E., Gijbels M.J., van Dijk K.W., Havekes L.M., Jong M.C. Protection from obesity in mice lacking the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1488-1493.
16. Grundmann S., Hans F.P., Kinniry S., Heinke J., Helbing T., Bluhm F., Sluijter J.P., Hoefer I., Pasterkamp G., Bode C., Moser M. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 2011, 123:999-1009.
17. Heneghan H.M., Miller N., McAnena O.J., O'Brien T., Kerin M.J. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J. Clin. Endocrinol. Metab. 2011, 96:E846-E850.
18. Hjelmborg J.B., Fagnani C., Silventoinen K., McGue M., Korkeila M., Christensen K., Rissanen A., Kaprio J. Genetic influences on growth traits of BMI: a longitudinal study of adult twins. Obes. Silver Spring 2008, 16:847-852.
19. Hulsmans M., Sinnaeve P., Van der Schueren B., Mathieu C., Janssens S., Holvoet P. Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. J. Clin. Endocrinol. Metab. 2012, 97:E1213-E1218.
20. Karolina D.S., Armugam A., Tavintharan S., Wong M.T., Lim S.C., Sum C.F., Jeyaseelan K. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 2011, 6:e22839.
21. Kikuchi K., Fukuda M., Ito T., Inoue M., Yokoi T., Chiku S., Mitsuyama T., Asai K., Hirose T., Aizawa Y. Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation. Nucleic Acids Res. 2009, 37:4987-5000.
22. Kim J.E., Chen J. Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004, 53:2748-2756.
23. Kopelman P. Health risks associated with overweight and obesity. Obes. Rev. 2007, 8(Suppl. l):13-17.
24. Lamothe B., Baudry A., Christoffersen C.T., De Meyts P., Jami J., Bucchini D., Joshi R.L. Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors. FEBS Lett. 1998, 426:381-385.
25. Ledoux S., Queguiner I., Msika S., Calderari S., Rufat P., Gasc J.M., Corvol P., Larger E. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008, 57:3247-3257.
26. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
27. Maes H.H., Neale M.C., Eaves L.J. Genetic and environmental factors in relative body weight and human adiposity. Behav. Genet. 1997, 27:325-351.
28. McLaughlin T., Lamendola C., Liu A., Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J. Clin. Endocrinol. Metab. 2011, 96:E1756-E1760.
29. McTernan P.G., Anderson L.A., Anwar A.J., Eggo M.C., Crocker J., Barnett A.H., Stewart P.M., Kumar S. Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. J. Clin. Endocrinol. Metab. 2002, 87:1327-1336.
30. Ortega F.J., Moreno-Navarrete J.M., Pardo G., Sabater M., Hummel M., Ferrer A., Rodriguez-Hermosa J.I., Ruiz B., Ricart W., Peral B., Fernandez-Real J.M. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 2010, 5:e9022.
31. Ortega F.J., Mercader J.M., Catalan V., Moreno-Navarrete J.M., Pueyo N., Sabater M., Gomez-Ambrosi J., Anglada R., Fernandez-Formoso J.A., Ricart W., Fruhbeck G., Fernandez-Real J.M. Targeting the circulating microRNA signature of obesity. Clin. Chem. 2013, 59:781-792.
32. Pek S., Tavintharan S., Woon K., Niyati J., Lim S.C., Sum C.F. Associations between pigment epithelium-derived factor, insulin resistance and high density lipoprotein. Diabet. Med. 2013, 30:1067-1074.
33. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion,. Nature 2004, 432:226-230.
34. Smith P.J., Wise L.S., Berkowitz R., Wan C., Rubin C.S. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J. Biol. Chem. 1988, 263:9402-9408.
35. Sucharov C., Bristow M.R., Port J.D. miRNA expression in the failing human heart: functional correlates. J. Mol. Cell Cardiol. 2008, 45:185-192.
36. Sylvius N., Bonne G., Straatman K., Reddy T., Gant T.W., Shackleton S. MicroRNA expression profiling in patients with lamin A/C-associated muscular dystrophy. FASEB J. 2011, 25:3966-3978.
37. Tao H., Hajri T. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists. Biochem. Pharmacol. 2011, 82:1950-1962.
38. Tavintharan S., Chi L.S., Fang S.C., Arunmozhiarasi A., Jeyaseelan K. Riboregulators and metabolic disorders: getting closer towards understanding the pathogenesis of diabetes mellitus?. Curr. Mol. Med. 2009, 9:281-286.
39. Tsui N.B., Ng E.K., Lo Y.M. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 2002, 48:1647-1653.
40. Vlachos I.S., Kostoulas N., Vergoulis T., Georgakilas G., Reczko M., Maragkakis M., Paraskevopoulou M.D., Prionidis K., Dalamagas T., Hatzigeorgiou A.G. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012, 40:W498-W504.
41. Wang X., Spandidos A., Wang H., Seed B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 2012, 40:D1144-D1149.
42. Wang L., Su W., Du W., Xu Y., Kong D., Han Z., Zheng G., Li Z. Gene and microRNA profiling of human induced pluripotent stem cell-derived endothelial cells. Stem Cell Rev. 2015, 11:219-227.
43. Wardle J., Carnell S., Haworth C.M., Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am. J. Clin. Nutr. 2008, 87:398-404.
44. Wong L.L., Wee A.S., Lim J.Y., Ng J.Y., Chong J.P., Liew O.W., Lilyanna S., Martinez E.C., Ackers-Johnson M.A., Vardy L.A., Armugam A., Jeyaseelan K., Ng T.P., Lam C.S., Foo R.S., Richards A.M., Chen Y.T. Natriuretic peptide receptor 3 (NPR3) is regulated by microRNA-100. J. Mol. Cell Cardiol. 2015, 82:13-21.
45. Zeng Y., Qu X., Li H., Huang S., Wang S., Xu Q., Lin R., Han Q., Li J., Zhao R.C. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett. 2012, 586:2375-2381.
46. Zhuang X., Li Z., Lin H., Gu L., Lin Q., Lu Z., Tzeng C.M. Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in non-obstructive azoospermia. Sci. Rep. 2015, 5:7922.